Pfizer pain drug Lyrica fails study in adolescents with fibromyalgia

(Reuters) - Pfizer Inc's pain drug, Lyrica, failed a post-marketing study testing the treatment in adolescents with fibromyalgia, a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news